Navigation Links
Aflac Announces Title Sponsorship of Outdoor Games
Date:5/13/2008

Columbus, GA to host collegiate and professional competitions airing

nationally on ESPN2 and ESPNU

COLUMBUS, Ga., May 13 /PRNewswire/ -- Aflac announced today that it has signed a two-year agreement as title sponsor of the Aflac Outdoor Games. The inaugural three-day event is scheduled for June 27 - 29, 2008 at the South Commons Softball Complex in Columbus, GA. Aflac Outdoor Games will include a variety of unique outdoor sports and activities including the STIHL(R) TIMBERSPORTS(R) Series which will be nationally televised on ESPN2 and ESPNU.

"We are excited about Aflac's title sponsorship of the Outdoor Games," said Paul Amos II, president and chief operating officer, Aflac U.S. "The event will help showcase Columbus to a national audience while providing families an opportunity to enjoy the great outdoors and witness some exciting sports entertainment."

Aflac Outdoor Games is a combination of several events including the Collegiate and Professional Championships of the STIHL(R) TIMBERSPORTS(R) Series, a competition consisting of eight competitive events that challenge competitors in the arenas of strength, endurance, stamina, tool skill and agility.

Aflac Outdoor Games has partnered with STIHL(R) to bring the STIHL(R) TIMBERSPORTS(R) Series to Columbus in 2008 and 2009. The events include Hot Saw, Stock Saw, Underhand Chop, Standing Chop, Single Buck Saw, Speed Climb, Springboard and the Boom Run. In addition to the STIHL(R) TIMBERSPORTS(R) Series, the Aflac Outdoor Games will be host to national and local barbeque cooking contests as well as sporting competitions for dogs. The 2008 Pig Bowl event will be officially endorsed by the Kansas City Barbeque Society, an organization that has sanctioned almost 300 barbeque contests throughout the United States. The dog competitions will include champion Agility Dog demonstrations, and a "DockDogs" event in which canines leap from a platform across a pool of wate
'/>"/>

SOURCE Aflac
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Aflac Incorporated to Webcast 2008 Financial Analysts Briefing
2. Aflac CEO Funds Breast Cancer Symposium in Honor of Companys African-American Female Employees
3. Aflac Shareholders Have Their Say-on-Pay,
4. Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend
5. Aflac Incorporated To Release First Quarter Results on April 23, 2008
6. Aflac Named Among the 50 Best Companies for Supplier Diversity
7. Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta
8. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
9. Training Magazine Applauds Aflacs Employee Learning Programs
10. Aflac Incorporated Announces Fourth Quarter Results
11. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...y Myanmar did not give him more than six months to...nd new life in a Delhi hospital which successfully...nessman from Mandalay underwent a 10-hour liver tr...Hospital, a leading private hospital in the capita...
... have trouble driving safely, according to a study...ssenger conversation puts drivers with Parkinson's...trols," said Dr. Ergin Y. CU of the University of ...nter in Iowa City to the reporters. The study was...
... Scotland hospitals causing an imbalance in the ov...ficial watchdog to ensure //that the standards of ... Scotland s Audit report 50% of the hospitals have...e of the diets the supply to patients who are in a...
...ion has reported that one in three cases of mental... following observations were made after studying t...ent readmission rates during the year 2003-2004. ...admitted, 45 percent of patients were those with a...
Other Medicine News:Health News:Myanmar National Undergoes Successful Liver Transplantation in Delhi 2Health News:Hospital Food Needs Improvement to Meet the Nutritional Needs of the Patient 2Health News:Mentally-Ill Patients Get Re-Hospitalized More 2
(Date:9/5/2008)...lif., Sept. 5 /- SARcode,Co...cule LFA-1 inhibitors,to treat inflammatory diseas...S) today announced SARcode,s initiation of a Phase...t candidate for T-cell mediated ophthalmic,disease...ement providing,SARcode with an exclusive license ...
(Date:9/5/2008)...croRNAs Extracted From a Simple Blood Draw Have,th...ers for a Wide Range of ...Rosetta Genomics is Currently Developing ...EHOVOT, Israel and JERSEY CITY, New Jersey, Septem...Ltd. (NASDQ: ROSG), a leader in,the development of...
(Date:9/4/2008)...esignation for the treatment of Acute Myeloid ....J., Sept. 4 /- Celator Pharmaceutica...istration (FDA) has granted orphan,drug designatio...jection,for the treatment of Acute Myeloid Leukemi...ct two randomized Phase 2,studies with CPX-351. Th...
(Date:9/4/2008)...Man(R) real-time PCR testing for the diagnostic ...alif., Sept. 4 /- The U.S. Food & Dru...S(R) TaqMan(R) HBV Test,the first assay for quant...,The test uses Roche,s real-time PCR technology to... patient,s blood. Doctors may use viral load,testi...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Regular marijuana use increases risk of hepatitis C related liver damage 10262 1Regular marijuana use increases risk of hepatitis C related liver damage 10262 2Regular marijuana use increases risk of hepatitis C related liver damage 10262 3Breakthrough Opportunity for Improving Patient Health 2779 1Pulmonary Fibrosis Patients 9 11 Responders Represented at State of the Union Address for Second Year in a Row 10258 1Pulmonary Fibrosis Patients 9 11 Responders Represented at State of the Union Address for Second Year in a Row 10258 2XLHealth Corporation Announces Executive Changes 10256 1XLHealth Corporation Announces Executive Changes 10256 2
...Phase III pivotal trial demonstrate safety and,eff...umarate for,patients with moderate to severe COPD ..., L.P. announced,that two clinical data presentati...of the American Thoracic Society (ATS) on,Sunday, ...e,presentations will detail Phase III clinical dat...
...ATION, N.J.--(BUSINESS WIRE)--May 17, 2007 - Resul...ck,s cervical cancer,vaccine, GARDASIL (Quadrivale...mbinant Vaccine) was 100 percent effective in,prev...used by HPV,types 16 and 18, two types strongly as...ection was observed in women who were not,infected...
Other Medicine Technology:Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...est is one of the easiest tests to run on the mark...s with no hands-on time. Critical care instruction...aving the pediatrician's office and valuable infor... to help control the spread of RSV infections. Now...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: